Fecal Microbiota Transplantation for Clostridium difficile-associated Diarrhea in Hematopoietic Stem Cell Transplant Recipients: A Single-center Experience from a Tertiary Center in India

Objectives

Fecal microbiota transplantation (FMT) is an emerging option for recurrent or refractory Clostridium difficile-associated diarrhea (CDAD). We describe a single-center experience of FMT in hematopoietic stem cell transplant (HSCT) recipients with CDAD in India.

Methods

A prospective observational study of HSCT recipients with CDAD who received FMT in our center.

Results

A total of 13 patients were included. All the patients were allogenic HSCT recipients; FMT was performed in seven patients due to refractory CDAD, in five patients due to the presence of both CDAD and graft vs host disease (GVHD), and in 1 patient due to recurrent CDAD. The approach to FMT was colonoscopic in 10 (77%) patients. Only one patient reported bacteremia and one patient had candidemia, both of which were unrelated to FMT. Of the 10 patients who had complete resolution of CDAD, only one patient presented with a recurrence of CDAD within 8 weeks post-FMT.

Conclusion

This is the first study from India using FMT as a therapeutic modality for CDAD in the setting of HSCT. Here we demonstrate that FMT in India is an effective option, especially when patients have refractory CDAD, recurrent CDAD, or both GVHD and CDAD. Further studies should explore the efficacy and feasibility of FMT in India.

How to cite this article

Prayag PS, Patwardhan SA, Ajapuje PS, Melinkeri S, Gadhikar H, Palnitkar S, et al. Fecal Microbiota Transplantation for Clostridium difficile-associated Diarrhea in Hematopoietic Stem Cell Transplant Recipients: A Single-center Experience from a Tertiary Center in India. Indian J Crit Care Med 2024;28(2):106-110.

PEFR in pregnancy: a longitudinal study

Peak expiratory flow rates (PEFR) were measured in 60 pregnant women aged 20-28 years (average 24 yrs) height between 130-160 cm (average 154.5 cm), each month beginning from 3rd month of gestation and also 8-10 weeks postpartum using, Wright's Peak Flow Meter. The PEFR declined from 329.12 +/- 4.40 lpm in 3rd month to 286.22 +/- 3.81 lpm in 9th month of gestation and increased to 347.86 +/- 2.93 lpm in postpartal period. A similar, declining trend is also observed in other Indian studies. However, the values are lower than those observed in Europeans. Also no change in PEFR during pregnancy was observed in an European study. The PEFR in our study regressed at a rate of 6.68 lpm/month of gestation and 5.49 lpm/kg increase in weight throughout pregnancy. The correlation with forced vital capacity (FVC) and forced expiratory volume in first second (FEV1) is non-significant throughout pregnancy. The anaemic pregnant women showed lower PEFR when compared with PEFR of nonanaemic pregnant women, but showed a similar declining trend throughout pregnancy.

A longitudinal study of pulmonary function tests during pregnancy

The study deals with evaluation of pulmonary function status in fifty normal pregnant women tested monthly. The parameters studied were Vital Capacity (VC) Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1st second (FEV1) using Vitalograph Spirometer; tidal volume (VT), inspiratory capacity (IC) and expiratory reserve volume (ERV) using Expirograph and resting minute ventilation (VE) using Tissot's spirometer. Control values were obtained in the same subject 8-10 weeks after delivery. The increase seen in VT, VE and IC was very highly significant. The small increment in frequency of respiration is significant and the declining trend observed in ERV is very highly significant. VC and FVC were maintained by the rise in IC and a concomitant fall in ERV. Rise in VC is attributed mainly to rise in VT than rise in frequency. The results suggest that though pulmonary function is altered during pregnancy, it is not compromised and hence does not induce any mechanical stress on the respiratory efficiency of the pregnant woman.

Serum level of iron and transferrin in pregnancy and postpartum period

This study presents a composite picture of haemoglobin (Hb), serum level of iron (SI), total iron binding capacity (TIBC) and percent iron saturation of transferrin in women during different trimesters of pregnancy and postpartum period. The results were correlated with age and parity. A total of 75 subjects, 15 from each trimester and 15 postpartal, were studied and compared with 15 nonpregnant normal subjects. Signs of increased iron demand, increased iron turnover and obvious iron deficiency, were demonstrated throughout pregnancy, by decrease in haemoglobin, SI, percent iron saturation of transferrin and increased TIBC; especially in older age group and multigravidae. SI, TIBC and percent iron saturation of transferrin are more sensitive indices of iron status and provide us an opportunity to replenish iron stores of an iron deficient pregnant mother at an earlier date thus preventing anaemia.

Action of some new insect growth regulators on mosquito vectors. Part II: Geraniol based diethers

Biological activity of saturated diethers viz. 1-benzyloxy/phenoxy-8-alkoxy and 1-alkoxy-8-benzyloxy-3,7-dimethyl-1, 8-octanes (IIa-IIq) prepared from Geraniol, were studied on three mosquito species and the bug Dysdercus koenigii. These diethers exhibited oviposition deterrent and developmental inhibition activities of greater magnitudes than the compounds based on citronellol reported in Part I of this paper. Some of these new compounds inhibit development of mosquitoes at 0.05 ppm and deter oviposition at 0.05 per cent doses. Tests were extended to field simulated conditions in selected cases.

Cyclopcidal activity of some new insect growth regulators

A series of synthetic terpenoid diethers, with known mosquito development inhibitory activity, were tested for cyclopcidal activity against adult cyclops, Mesocyclops leuckarti. Four among these exhibited promising activity comparable to that of the conventional organophosphate, temephos, thus providing for the first time a possible reserve arsenal for the control of the guineaworm disease vector.